Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Neurology 5, 578 (1 November 2009) | doi:10.1038/nrneurol.2009.170
Multiple sclerosis: Predicting the response to IFN-|[beta]| treatment in patients with MS
Abstract
Comabella, M. et al. A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis. Brain doi:10.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
